As of 2025-08-07, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 14.0x | 13.5x |
| Forward P/E multiples | 18.3x - 31.9x | 23.5x |
| Fair Price | (225.69) - (174.41) | (228.12) |
| Upside | -4641.1% - -3609.3% | -4690.0% |
| Date | EV/EBITDA |
| 2025-05-30 | -1.11 |
| 2025-05-29 | -1.11 |
| 2025-05-28 | -1.11 |
| 2025-05-27 | -1.12 |
| 2025-05-23 | -1.11 |
| 2025-05-22 | -1.11 |
| 2025-05-21 | -1.11 |
| 2025-05-20 | -1.11 |
| 2025-05-19 | -1.11 |
| 2025-05-16 | -1.11 |
| 2025-05-15 | -1.11 |
| 2025-05-14 | -1.11 |
| 2025-05-13 | -0.97 |
| 2025-05-12 | -0.97 |
| 2025-05-09 | -0.99 |